Requip Depot 2 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

requip depot 2 mg depottabletti

glaxosmithkline oy - ropinirole hydrochloride - depottabletti - 2 mg - ropiniroli

Requip Depot 4 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

requip depot 4 mg depottabletti

glaxosmithkline oy - ropinirole hydrochloride - depottabletti - 4 mg - ropiniroli

Requip Depot 8 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

requip depot 8 mg depottabletti

glaxosmithkline oy - ropinirole hydrochloride - depottabletti - 8 mg - ropiniroli

Ropinirol Krka 2 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol krka 2 mg depottabletti

krka sverige ab - ropinirole hydrochloride - depottabletti - 2 mg - ropiniroli

Ropinirol Krka 4 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol krka 4 mg depottabletti

krka sverige ab - ropinirole hydrochloride - depottabletti - 4 mg - ropiniroli

Ropinirol Krka 8 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol krka 8 mg depottabletti

krka sverige ab - ropinirole hydrochloride - depottabletti - 8 mg - ropiniroli

ROPINIROL SANDOZ 2 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol sandoz 2 mg depottabletti

sandoz a/s sandoz a/s - ropiniroli hydrochloridum - depottabletti - 2 mg - ropiniroli

ROPINIROL SANDOZ 4 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol sandoz 4 mg depottabletti

sandoz a/s sandoz a/s - ropiniroli hydrochloridum - depottabletti - 4 mg - ropiniroli

ROPINIROL SANDOZ 8 mg depottabletti Финляндия - финский - Fimea (Suomen lääkevirasto)

ropinirol sandoz 8 mg depottabletti

sandoz a/s sandoz a/s - ropiniroli hydrochloridum - depottabletti - 8 mg - ropiniroli

Libmeldy Европейский союз - финский - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - muut hermoston huumeet - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.